M. Azuma et al., Evaluation of portosystemic collaterals by SPECT imaging after endoscopic variceal sclerotherapy: Usefulness for predicting recurrence, J NUCL MED, 41(4), 2000, pp. 600-604
Citations number
17
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
Bleeding from esophageal varices is a major cause of morbidity and mortalit
y in cirrhotic patients. Identification of patients at high risk for bleedi
ng is particularly important. The aim of this study was to determine whethe
r detection of portosystemic collaterals by SPECT could predict the outcome
of endoscopic injection sclerotherapy of esophageal varices and be useful
for selecting appropriate therapy. Methods: Sixty-two patients with liver-c
irrhosis who were considered at high risk of bleeding were treated with end
oscopic injection sclerotherapy. Endoscopy was performed every 3 mo after t
herapy or until bleeding occurred. Before and within 2 wk after therapy, to
mographic images of intra-abdominal blood pool were constructed by SPECT. R
esults: Before therapy, the following portosystemic collateral routes were
observed: coronary veins in 53 (85.5%) of 62 patients, short gastric veins
in 8 patients (12.9%), splenorenal shunts in 10 patients (16.1%), and parau
mbilical veins in 6 patients (9.7%). Patients positive for imaging of coron
ary veins were divided into 3 groups on the basis of changes in images afte
r therapy: complete responders (n = 17), whose coronary vein images disappe
ared completely; partial responders (n = 18), whose images became smaller;
and nonresponders (n = 18), whose images did not change significantly befor
e or after therapy. The rates of recurrence after endoscopic injection scle
rotherapy until 6 mo in complete responders (4/17, 23.5%) and partial respo
nders (7/18, 38.9%) were significantly less (P < 0.05) than that in nonresp
onders (11/13, 84.6%). The rate of recurrence of esophageal varices until 6
mo in nonresponders treated with additional submucosal injection sclerothe
rapy (1/5, 20.0%) was significantly less (P < 0.05) than that in nonrespond
ers without additional submucosal injection sclerotherapy (11/13, 84.6%). C
onclusion: Abdominal blood-pool SPECT, a noninvasive method, is useful for
evaluating the therapeutic effectiveness of endoscopic sclerotherapy, for p
redicting the recurrence of varices, and for selecting appropriate manageme
nt after sclerotherapy.